TNNI3 and cardiotoxicity: Despite there beinga general consensus on the role of echocardiography in diagnosinganthracycline-related cardiotoxicity, the optimal timeframe to perform it and theoptimal parameters to be evaluated for the diagnosis are still matter of debate.Biomarkers such as cTnI/T and NP have proved to have a good negative predictivevalue for anthracycline-related cardiotoxicity and as such, most recentguidelines recommend their serial measurement during follow-up.